Related Experiment Video
Updated: Apr 19, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression
Guangye Han1, Maochuan Fan1, Xinjun Zhang1
1Urology Department, The First Affiliated Hospital of Xinxiang Medical University, Henan 453100, China.
Abstract:
The tumor protein D52 (TPD52) is an oncogene overexpressed in prostate cancer (PC) due to gene amplification. Although the oncogenic effect of TPD52 is well recognized, how its expression is regulated is still not clear. This study tried to explore the regulative role of miR-218, a tumor suppressing miRNA on TPD52 expression and prostate cancer cell proliferation. We found the expression of miR-218 was significantly lower in PC specimens. Based on gain and loss of function analysis, we found miR-218 significantly inhibit cancer cell proliferation by inducing apoptosis. These results strongly suggest that miR-218 plays a tumor suppressor role in PC cells. In addition, our data firstly demonstrated that miR-218 directly regulates oncogenic TPD52 in PC3 cells and the miR-218-TPD52 axis can regulate growth of this prostate cancer cell line. Knockdown of TPD52 resulted in significantly increased cancer cell apoptosis. Clearly understanding of oncogenic TPD52 pathways regulated by miR-218 might be helpful to reveal new therapeutic targets for PC.
Insights
MicroRNA-218 (miR-218) acts as a tumor suppressor by inhibiting prostate cancer cell proliferation and directly regulating the oncogene tumor protein D52 (TPD52). Lower miR-218 levels correlate with prostate cancer, suggesting therapeutic potential.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Tumor protein D52 (TPD52) is an oncogene overexpressed in prostate cancer (PC) via gene amplification.
- The regulatory mechanisms controlling TPD52 expression in PC remain unclear.
Purpose of the Study:
- To investigate the role of miR-218, a tumor-suppressing microRNA, in regulating TPD52 expression and prostate cancer cell proliferation.
- To elucidate the miR-218-TPD52 axis in prostate cancer progression.
Main Methods:
- Analysis of miR-218 expression in PC specimens.
- Gain and loss of function experiments to assess miR-218's effect on cell proliferation and apoptosis.
- Direct regulation validation of miR-218 on TPD52 in PC3 cells.
- TPD52 knockdown experiments.
Main Results:
- miR-218 expression was significantly lower in PC specimens.
- miR-218 inhibited prostate cancer cell proliferation by inducing apoptosis.
- miR-218 directly targets and regulates TPD52 expression in PC3 cells.
- TPD52 knockdown increased cancer cell apoptosis.
Conclusions:
- miR-218 functions as a tumor suppressor in prostate cancer.
- The miR-218-TPD52 pathway is a critical regulator of prostate cancer cell growth.
- Understanding this axis may reveal novel therapeutic targets for prostate cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation

